Background: Neuropathological studies indicate concomitant Alzheimer's disease (AD)
pathology in patients with dementia with Lewy bodies (DLB). Objectives: To measure …

Correct in vivo diagnosis of Alzheimer's disease (AD) helps to avoid administration of
disease-modifying treatments in non-AD patients, and allows the possible use of such …

Background: Cerebral amyloid angiopathy (CAA) is characterized by deposition of amyloid
in small/medium size brain vessels, and may coexist with Alzheimer's disease or dementia …

The classical cerebrospinal fluid biomarkers of Alzheimer's Disease (namely total tau,
phospho-tau and amyloid beta peptide) have received much attention, since they can detect …

The core (established) cerebrospinal fluid biomarkers of Alzheimer's disease (AD), namely
amyloid-beta peptide, total tau protein and phospho-tau protein, have become a part of the …